Comparison of buspirone in two separate studies.
Two double-blind studies are described in which buspirone was compared with placebo and diazepam (Study A) or clorazepate (Study B) in outpatients with moderate to severe anxiety. Results, assessed on the Hamilton Rating Scales for Depression and Anxiety, the SCL-56, the Profile of Mood States, and the Covi and Raskin scales, indicated that buspirone consistently relieved both anxiety and associated depression. In Study B, trends in favor of buspirone were seen on several SCL-56 items and the Hamilton somatic factor; significant differences in this direction were found for several POMS items. Sedation was seen less often with buspirone than either diazepam or clorazepate.
D000328:Adult; D000553:Ambulatory Care; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D002065:Buspirone; D002986:Clinical Trials as Topic; D003009:Clorazepate Dipotassium / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000523:psychology; D003975:Diazepam / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010555:Personality Inventory; D011569:Psychiatric Status Rating Scales; D011743:Pyrimidines / Q000627:therapeutic use*
D011743:Pyrimidines; D003009:Clorazepate Dipotassium; D003975:Diazepam; D002065:Buspirone